Provident Financial Services, Inc. Announces First Quarter Earnings and Declares Quarterly Cash Dividend
April 18, 2024 17:00 ET
|
Provident Financial Services, Inc.
ISELIN, N.J., April 18, 2024 (GLOBE NEWSWIRE) -- Provident Financial Services, Inc. (NYSE:PFS) (the “Company”) reported net income of $32.1 million, or $0.43 per basic and diluted share for the...
Arbutus to Report First Quarter 2024 Financial Results and Provide Corporate Update
April 18, 2024 07:30 ET
|
Arbutus Biopharma Corporation
WARMINSTER, Pa., April 18, 2024 (GLOBE NEWSWIRE) -- Arbutus Biopharma Corporation (Nasdaq: ABUS), a clinical-stage biopharmaceutical company leveraging its extensive virology expertise to develop a...
Triumph Financial Releases First Quarter 2024 Financial Results
April 17, 2024 16:07 ET
|
Triumph Financial, Inc.
DALLAS, April 17, 2024 (GLOBE NEWSWIRE) -- Triumph Financial, Inc. (Nasdaq: TFIN) has released its first quarter 2024 financial results. The 1Q 2024 financial results and shareholder letter are...
Provident Financial Services, Inc. Schedules First Quarter Earnings Conference Call
April 11, 2024 09:00 ET
|
Provident Financial Services, Inc.
ISELIN, N.J., April 11, 2024 (GLOBE NEWSWIRE) -- Provident Financial Services, Inc. (NYSE: PFS) announced that it expects to release financial results for the quarter ended March 31, 2024 on...
Triumph Financial Announces Schedule for First Quarter 2024 Earnings Release and Conference Call
April 05, 2024 16:07 ET
|
Triumph Financial, Inc.
DALLAS, April 05, 2024 (GLOBE NEWSWIRE) -- Triumph Financial, Inc. (Nasdaq: TFIN) today announced that it expects to release its first quarter financial results and management commentary after the...
Optinose to Present at the Needham Virtual Healthcare Conference
April 04, 2024 16:01 ET
|
Optinose, Inc.
YARDLEY, Pa., April 04, 2024 (GLOBE NEWSWIRE) -- Optinose (NASDAQ:OPTN), a pharmaceutical company focused on patients treated by ear, nose and throat (ENT) and allergy specialists, today announced...
Altamira Therapeutics to Host Full Year 2023 Financial Results and Business Update Call on April 10, 2024
April 04, 2024 08:45 ET
|
Altamira Therapeutics Ltd
Hamilton, Bermuda, April 04, 2024 (GLOBE NEWSWIRE) -- Altamira Therapeutics Ltd. ("Altamira" or the "Company") (Nasdaq: CYTO), a company providing nanoparticle-based technology for efficient RNA...
Eagle Bancorp Announces Earnings Call on April 25, 2024
April 03, 2024 06:00 ET
|
Eagle Bancorp, Inc.
BETHESDA, Md., April 03, 2024 (GLOBE NEWSWIRE) -- Eagle Bancorp, Inc., (the “Company”) (NASDAQ: EGBN), the parent company of EagleBank, today announced that it will host a teleconference call for...
Yield10 Bioscience Announces Fourth Quarter and Full Year 2023 Financial Results
April 01, 2024 16:01 ET
|
Yield10 Bioscience, Inc.
-Granted global commercial license to Vision Bioenergy for Camelina addressing the biofuel market-Advanced regulatory and seed scale-up program for omega-3 Camelina-E3902 oil trait in Camelina cleared...
Yield10 Bioscience to Announce Fourth Quarter and Full Year 2023 Financial Results and Host a Conference Call on Monday, April 1, 2024
March 28, 2024 16:01 ET
|
Yield10 Bioscience, Inc.
WOBURN, Mass., March 28, 2024 (GLOBE NEWSWIRE) -- Yield10 Bioscience, Inc. (Nasdaq:YTEN) (“Yield10” or the “Company”), an agricultural bioscience company, today announced that the Company will...